Atherosclerosis
Volume 194, Issue 2 , Pages e172-e178 , October 2007

Genetic risk for restenosis after coronary stenting

  • Mitsutoshi Oguri

      Affiliations

    • Department of Cardiovascular Medicine, Gifu Prefectural Tajimi Hospital, 5-161 Maehata, Tajimi, Gifu 507-8522, Japan
    • ,
  • Kimihiko Kato

      Affiliations

    • Department of Cardiovascular Medicine, Gifu Prefectural Tajimi Hospital, 5-161 Maehata, Tajimi, Gifu 507-8522, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 572 22 5311; fax: +81 572 25 1246.
    • ,
  • Takeshi Hibino

      Affiliations

    • Department of Cardiovascular Medicine, Gifu Prefectural Tajimi Hospital, 5-161 Maehata, Tajimi, Gifu 507-8522, Japan
    • ,
  • Kiyoshi Yokoi

      Affiliations

    • Department of Cardiovascular Medicine, Gifu Prefectural Tajimi Hospital, 5-161 Maehata, Tajimi, Gifu 507-8522, Japan
    • ,
  • Tomonori Segawa

      Affiliations

    • Department of Cardiology, Gifu Prefectural Gifu Hospital, Gifu, Japan
    • ,
  • Hitoshi Matsuo

      Affiliations

    • Department of Cardiology, Gifu Prefectural Gifu Hospital, Gifu, Japan
    • ,
  • Sachiro Watanabe

      Affiliations

    • Department of Cardiology, Gifu Prefectural Gifu Hospital, Gifu, Japan
    • ,
  • Yoshinori Nozawa

      Affiliations

    • Gifu International Institute of Biotechnology, Kakamigahara, Japan
    • ,
  • Toyoaki Murohara

      Affiliations

    • Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    • ,
  • Yoshiji Yamada

      Affiliations

    • Gifu International Institute of Biotechnology, Kakamigahara, Japan
    • Department of Human Functional Genomics, Life Science Research Center, Mie University, Tsu, Japan

Received 28 June 2006 ,Revised 23 November 2006 ,Accepted 17 December 2006.

References 

  1. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
  2. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–1780
  3. Biondi-Zoccai GG, Agostoni P, Abbate A, et al. Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials. Int J Cardiol. 2005;100:119–123
  4. Kim YH, Park SW, Lee CW, et al. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions. Catheter Cardiovasc Interv. 2006;67:181–187
  5. Spaulding C, Henry P, Teiger E, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med. 2006;355:1093–1104
  6. Kereiakes DJ. Hippocrates revisited: the evidence for drug-eluting stents. Circulation. 2003;107:3012–3014
  7. Kaiser C, Brunner-La Rocca HP, Buser PT, et al. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET). Lancet. 2005;366:921–929
  8. Cohen DJ, Bakhai A, Shi C, et al. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation. 2004;110:508–514
  9. Kong DF, Eisenstein EL, Sketch MH, et al. Economic impact of drug-eluting stents on hospital systems: a disease-state model. Am Heart J. 2004;147:449–456
  10. Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006;113:1108–1113
  11. Lemos PA, Serruys PW, Sousa JE. Drug-eluting stents: cost versus clinical benefit. Circulation. 2003;107:3003–3007
  12. O’Neill WW, Leon MB. Drug-eluting stents: costs versus clinical benefit. Circulation. 2003;107:3008–3011
  13. Itoh Y, Mizuki N, Shimada T, et al. High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics. 2005;57:717–729
  14. Casagrande JT, Pike MC. An improved approximate formula for calculating sample sizes for comparing two binomial distributions. Biometrics. 1978;34:483–486
  15. Feigl P. A graphical aid for determining sample size when comparing two independent proportions. Biometrics. 1978;34:111–122
  16. Slager SL, Schaid DJ. Case-control studies of genetic markers: power and sample size approximations for Armitage's test for trend. Hum Hered. 2001;52:149–153
  17. Gomma AH, Elrayess MA, Knight CJ, et al. The endothelial nitric oxide synthase (Glu298Asp and –786T→C) gene polymorphisms are associated with coronary in-stent restenosis. Eur Heart J. 2002;23:1955–1962
  18. Inoue T, Uchida T, Yaguchi I, et al. Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis. Circulation. 2003;107:1757–1763
  19. Kastrati A, Schomig A, Seyfarth M, et al. PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation. 1999;99:1005–1010
  20. Amant C, Bauters C, Bodart JC, et al. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation. 1997;96:56–60
  21. Mitra AK, Agrawal DK. In stent restenosis: bane of the stent era. J Clin Pathol. 2006;59:232–239
  22. Virmani R, Kolodgie FD, Farb A, et al. Drug eluting stents: are human and animal studies comparable?. Heart. 2003;89:133–138
  23. Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation. 1996;94:1247–1254
  24. Grewe PH, Deneke T, Machraoui A, et al. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol. 2000;35:157–163
  25. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2000;103:211–225
  26. Neckameyer WS, Wang LH. Nucleotide sequence of avian sarcoma virus UR2 and comparison of its transforming gene with other members of the tyrosine protein kinase oncogene family. J Virol. 1985;53:879–884
  27. Birchmeier C, O’Neill K, Riggs M, et al. Characterization of ROS1 cDNA from a human glioblastoma cell line. Proc Natl Acad Sci USA. 1990;87:4799–4803
  28. Zong CS, Chan JL, Yang SK, et al. Mutations of Ros differentially effecting signal transduction pathways leading to cell growth versus transformation. J Biol Chem. 1997;272:1500–1506
  29. Shiffman D, Ellis SG, Rowland CM, et al. Identification of four gene variants associated with myocardial infarction. Am J Hum Genet. 2005;77:596–605
  30. Valle A, O’Connor DT, Taylor PW, et al. Pseudocholinesterase: association with the metabolic syndrome and identification of 2 gene loci affecting activity. Clin Chem. 2006;52:1014–1020
  31. Vionnet N, Hani El-H, Dupont S, et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet. 2000;67:1470–1480
  32. Bartels CF, Jensen FS, Lockridge O, et al. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet. 1992;50:1086–1103
  33. Minor DL, Kim PS. Measurement of the beta-sheet-forming propensities of amino acids. Nature. 1994;367:660–663
  34. Blankenberg S, Rupprecht HJ, Bickel C, et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med. 2003;349:1605–1613
  35. Hamanishi T, Furuta H, Kato H, et al. Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patients. Diabetes. 2004;53:2455–2460

PII: S0021-9150(06)00761-1

doi: 10.1016/j.atherosclerosis.2006.12.019

Atherosclerosis
Volume 194, Issue 2 , Pages e172-e178 , October 2007

Article Tools